12/2/2020, 8:35 AM (Source: TeleTrader)
more TeleTrader news

Pfizer CEO: UK's vaccine approval historic moment

Chief Executive Officer (CEO) of Pfizer Inc. Albert Bourla stated on Wednesday the approval of the vaccine candidate against COVID-19, developed by the company in partnership with BioNTech SE, in the United Kingdom was a "historic moment" in combating the ongoing pandemic and another proof the "science will win."

"As we anticipate further authorizations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world," Bourla said. "With thousands of people becoming infected, every day matters in the collective race to end this devastating pandemic."

Earlier in the day, Britain's Department of Health and Social Care (DHS) announced Pfizer and BioNTech's vaccine candidate had been granted an emergency use authorization in that country, set to roll out as early as next week.

Breaking the News / JR